88 related articles for article (PubMed ID: 8331535)
1. Absorption, bioavailability, and pharmacokinetics of tebufelone in the rat.
Sietsema WK; Kelm GR; Deibel RM; Doyle MJ; Loomans ME; Smyth RE; Kinnett GO; Eichhold TH; Farmer RW
J Pharm Sci; 1993 Jun; 82(6):610-2. PubMed ID: 8331535
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tebufelone distribution in rat blood plasma and inflamed and noninflamed tissues following peroral and intravenous administration.
Doyle MJ; Eichhold TH; Loomans ME; Farmer RW; Kelm GR
J Pharm Sci; 1993 Aug; 82(8):847-50. PubMed ID: 8377126
[TBL] [Abstract][Full Text] [Related]
3. Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology.
Cruze CA; Kelm GR; Meredith MP
Pharm Res; 1995 Jun; 12(6):895-901. PubMed ID: 7667197
[TBL] [Abstract][Full Text] [Related]
4. Antipyretic activity of tebufelone (NE-11740) in man.
Powell JH; Meredith MP; Vargas R; McMahon FG; Jain AK
Agents Actions Suppl; 1991; 32():45-9. PubMed ID: 2069096
[TBL] [Abstract][Full Text] [Related]
5. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
[TBL] [Abstract][Full Text] [Related]
6. Determination of tebufelone, a new anti-inflammatory drug, in plasma and tissue using capillary gas chromatography/stable isotope dilution mass spectrometry.
Eichhold TH; Doyle MJ
Biomed Environ Mass Spectrom; 1990 Apr; 19(4):230-4. PubMed ID: 2340361
[TBL] [Abstract][Full Text] [Related]
7. Automated gas chromatography/tandem mass spectrometry assay for tebufelone and a 13C,(18)O-labeled analog in plasma: applicabilityto absolute bioavailability determination.
Dobson RL; Kelm GR; Neal DM
Biol Mass Spectrom; 1994 Feb; 23(2):75-81. PubMed ID: 8123692
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of magnolin in rats.
Kim NJ; Song WY; Yoo SD; Oh SR; Lee HK; Lee HS
Arch Pharm Res; 2010 Jun; 33(6):933-8. PubMed ID: 20607499
[TBL] [Abstract][Full Text] [Related]
10. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
[TBL] [Abstract][Full Text] [Related]
11. Determination of tebufelone (a new anti-inflammatory drug) strength and stability in bulk drug, dosage formulations and feed admixtures by reversed-phase high-performance liquid chromatography.
Kaffenberger RM; Eichhold TH; Doyle MJ
J Chromatogr; 1990 May; 505(2):349-56. PubMed ID: 2355065
[TBL] [Abstract][Full Text] [Related]
12. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
[TBL] [Abstract][Full Text] [Related]
13. Absorption, bioavailability, and metabolism of para-nonylphenol in the rat.
Green T; Swain C; Van Miller JP; Joiner RL
Regul Toxicol Pharmacol; 2003 Aug; 38(1):43-51. PubMed ID: 12878053
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a benchtop ion trap gas chromatographic-tandem mass spectrometric instrument for the analysis of a model drug, tebufelone, in plasma using a stable-isotope internal standard.
Wehmeyer KR; Knight PM; Parry RC
J Chromatogr B Biomed Appl; 1996 Feb; 676(1):53-9. PubMed ID: 8852044
[TBL] [Abstract][Full Text] [Related]
15. Automated gas chromatography/tandem mass spectrometry with on-line chemical derivatization for the determination of tebufelone and two metabolites in human plasma.
Dobson RL; Dirr MK; Merkt BL
J Mass Spectrom; 1997 Dec; 32(12):1290-8. PubMed ID: 9423282
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Biodistribution, Excretion and Plasma Protein Binding Studies of Acteoside in Rats.
Wen Y; Huo S; Zhang W; Xing H; Qi L; Zhao D; Li N; Xu J; Yan M; Chen X
Drug Res (Stuttg); 2016 Mar; 66(3):148-53. PubMed ID: 26241371
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics and bioavailability of oral and intravenous 1,1-dichloroethylene.
Putcha L; Bruckner JV; D'Souza R; Desai F; Feldman S
Fundam Appl Toxicol; 1986 Feb; 6(2):240-50. PubMed ID: 3699314
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
Kölle EU; Vollmer KO
Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
[TBL] [Abstract][Full Text] [Related]
19. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in plasma and urine metabolites from Sprague-Dawley rats after oral administration of normal and high doses of hydroxytyrosol, hydroxytyrosol acetate, and DOPAC.
Domínguez-Perles R; Auñón D; Ferreres F; Gil-Izquierdo A
Eur J Nutr; 2017 Feb; 56(1):215-224. PubMed ID: 26463517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
